Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye considers Polygiene’s Q4'25 figures to be soft, missing our expectations by 18% on top-line, primarily driven by lower Polygiene sales.</li><li>Subsequently, EBITDA missed our expectations, driven by the lower sales and one-time CEO shift costs impacting the quarter.</li><li>We expect to make downward estimate adjustments for 2026 while remaining positive to the long-term outlook.</li></ul>

Redeye considers Polygiene’s Q4'25 figures to be soft, missing our expectations by 18% on top-line, primarily driven by lower Polygiene sales.Subsequently, EBITDA missed our expectations, driven by the lower sales and one-time CEO shift costs impacting the quarter.We expect to make downward estimate adjustments for 2026 while remaining positive to the long-term outlook.

Polygiene Group (Q4 Initial take): Softer-than-Expected